Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Wangjie Yu"'
Autor:
Dianne Pham, Carly J. Deter, Mariah C. Reinard, Gregory A. Gibson, Kirill Kiselyov, Wangjie Yu, Vlad C. Sandulache, Claudette M. St. Croix, Kazunori Koide
Publikováno v:
ACS Central Science, Vol 6, Iss 10, Pp 1772-1788 (2020)
Externí odkaz:
https://doaj.org/article/5c507a83e7814c2aaa1a02472a8c9d4c
Autor:
Ratna Veeramachaneni, Wangjie Yu, Jared M Newton, Jan O Kemnade, Heath D Skinner, Andrew G Sikora, Vlad C Sandulache
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Background Metformin is a commonly used antidiabetic medication which has demonstrated promise as an anticancer agent alone and in combination with conventional treatment regimens. There is increasing evidence that metformin can also generate immunom
Externí odkaz:
https://doaj.org/article/fa7f5b93207b47babfaf128e1c021790
Autor:
Wangjie Yu, Yunyun Chen, Nagireddy Putluri, Cristian Coarfa, Matthew J. Robertson, Vasanta Putluri, Fabio Stossi, Julien Dubrulle, Michael A. Mancini, Jonathan C. Pang, Trung Nguyen, Dodge Baluya, Jeffrey N. Myers, Stephen Y. Lai, Vlad C. Sandulache
Publikováno v:
Cancers, Vol 12, Iss 6, p 1670 (2020)
Background: Cisplatin (CDDP) is commonly utilized in the treatment of advanced solid tumors including head and neck squamous cell carcinoma (HNSCC). Cisplatin response remains highly variable among individual tumors and development of cisplatin resis
Externí odkaz:
https://doaj.org/article/d743c9a367cb4ce993ed8b6bb46eb28a
Publikováno v:
PLoS Genetics, Vol 12, Iss 11, p e1006430 (2016)
The Drosophila circadian oscillator controls daily rhythms in physiology, metabolism and behavior via transcriptional feedback loops. CLOCK-CYCLE (CLK-CYC) heterodimers initiate feedback loop function by binding E-box elements to activate per and tim
Externí odkaz:
https://doaj.org/article/5ca9bf9b2a754ca7b4fa7a8fb4a747c8
Autor:
Abdullah A. Osman, Emre Arslan, Mason Bartels, Chieko Michikawa, Antje Lindemann, Katarzyna Tomczak, Wangjie Yu, Vlad Sandulache, Wencai Ma, Li Shen, Jing Wang, Anand K. Singh, Mitchell J. Frederick, Nakia D. Spencer, Jeffery Kovacs, Timothy Heffernan, William F. Symmans, Kunal Rai, Jeffrey N. Myers
Publikováno v:
Clinical Cancer Research. 29:1344-1359
Purpose: Cisplatin (CDDP)-based chemotherapy is a first-line treatment for patients with advanced head and neck squamous cell carcinomas (HNSCC), despite a high rate of treatment failures, acquired resistance, and subsequent aggressive behavior. The
Autor:
Jeffrey N. Myers, Kunal Rai, William F. Symmans, Timothy Heffernan, Jeffery Kovacs, Nakia D. Spencer, Mitchell J. Frederick, Anand K. Singh, Jing Wang, Li Shen, Wencai Ma, Vlad Sandulache, Wangjie Yu, Katarzyna Tomczak, Antje Lindemann, Chieko Michikawa, Mason Bartels, Emre Arslan, Abdullah A. Osman
In vivo RNA sequencing and pair-wise comparison between 4 distinct groups in HN30-P and HN30-R8 HNSCC tumors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bd115b418deeae1124f97131e6285c2
https://doi.org/10.1158/1078-0432.22494750
https://doi.org/10.1158/1078-0432.22494750
Autor:
Jeffrey N. Myers, Kunal Rai, William F. Symmans, Timothy Heffernan, Jeffery Kovacs, Nakia D. Spencer, Mitchell J. Frederick, Anand K. Singh, Jing Wang, Li Shen, Wencai Ma, Vlad Sandulache, Wangjie Yu, Katarzyna Tomczak, Antje Lindemann, Chieko Michikawa, Mason Bartels, Emre Arslan, Abdullah A. Osman
Restoration of KEAP1/NRF2 pathways increases cisplatin sensitivity in resistant HNSCC cells through ferroptosis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a2c39503ad676647284b8b533ed237f
https://doi.org/10.1158/1078-0432.22494765.v1
https://doi.org/10.1158/1078-0432.22494765.v1
Autor:
Jeffrey N. Myers, Kunal Rai, William F. Symmans, Timothy Heffernan, Jeffery Kovacs, Nakia D. Spencer, Mitchell J. Frederick, Anand K. Singh, Jing Wang, Li Shen, Wencai Ma, Vlad Sandulache, Wangjie Yu, Katarzyna Tomczak, Antje Lindemann, Chieko Michikawa, Mason Bartels, Emre Arslan, Abdullah A. Osman
Purpose:Cisplatin (CDDP)-based chemotherapy is a first-line treatment for patients with advanced head and neck squamous cell carcinomas (HNSCC), despite a high rate of treatment failures, acquired resistance, and subsequent aggressive behavior. The p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41c04850927811f29801f3067657f18d
https://doi.org/10.1158/1078-0432.c.6533191.v2
https://doi.org/10.1158/1078-0432.c.6533191.v2
Autor:
Jeffrey N. Myers, Kunal Rai, William F. Symmans, Timothy Heffernan, Jeffery Kovacs, Nakia D. Spencer, Mitchell J. Frederick, Anand K. Singh, Jing Wang, Li Shen, Wencai Ma, Vlad Sandulache, Wangjie Yu, Katarzyna Tomczak, Antje Lindemann, Chieko Michikawa, Mason Bartels, Emre Arslan, Abdullah A. Osman
Supplementary Materials and Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78a4d28fe5032cc717680b8ae29d5b5f
https://doi.org/10.1158/1078-0432.22490656.v1
https://doi.org/10.1158/1078-0432.22490656.v1
Autor:
Wangjie Yu, Cristian Coarfa, Ananth Annapragada, Min Wang, Tej K. Pandita, Ratna Veeramachaneni, Vlad C. Sandulache, Sandra L. Grimm, Sergio Jaramillo, Michelle Ludwig, Kassidy A. Hebert, Mark D. Bonnen, Yohannes T. Ghebre, Farrah Kheradmand, David B. Corry, George Miles, Andrew G. Sikora, Shixia Huang, Dimuthu Perera, Raj K. Pandita
Publikováno v:
Oncotarget
The resistance of cancer cells to radiation-based treatment is a major clinical challenge confounding standard of care in cancer. This problem is particularly notable in many solid tumors where cancer cells are only partially responsive to radiation